Menu Close

Director of Formulations and Manufacturing Shares Successful Case Study: Rapid, Science-Driven Success in Early Phase Pharmaceutical Development.

QCL demonstrates success in early phase pharmaceutical development. Dr Emily Ware, Director of Formulations and Manufacturing at QCL, and lead formulation Scientist, Robert Sciscento developed two dosage types avoiding first-pass metabolism in the gut. The lead dosage form was prepared for First in Human trials within 6 months of project inception. Read full case study for additional details.

Read Full Article

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.